NDC 68462-405
Asprin And Extended-Release Dipyridamole 25 mg / 200 mg capsule
On the label: Glenmark Pharmaceuticals Inc., USA.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Recalls
- Jun 29, 2022 · Class III · Glenmark Pharmaceuticals Inc., USA
Failed Tablet/Capsule Specification : Capsule breakage
Lots: Lot#: 17201639, Exp 08/2022; 17201759, Exp 09/2022; 17202067, Exp 10/2022; 17210696, Exp 02/2023; 17210092, Exp 11/2022; 17210145, Exp 12/2022; 17210732, Exp 02/2023; 17211062, Exp 04/2023; 17211441, Exp 05/2023; 17211670, Exp 06/2023; 17211810, Exp 07/2023; 17211862, 17212020, 17212068, Exp 08/202…
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Aspirin and Dipyridamole: every company that makes it
- Form
- capsule, oral
- Strength
- 25 mg / 200 mg
- Approval
- ANDA ANDA210318
- On the market since
- May 24, 2019
- Package NDCs
68462-405-3068462-405-60- Official label
- DailyMed (National Library of Medicine), updated Jan 5, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?